However, contrasting results obtained with adult GBM samples have shown CD133-positive and negative cells as able to convert into each other [66,67] and equally endowed with tumor initiation capacity [66,68], which dramatically requestioned the relevance of CD133 as an accurate marker of adult GSCs. The gene discussed is PROM1; the disease is glioblastoma.